HbA1c and lower-extremity amputation risk in low-income patients with diabetes

Diabetes Care

Volumn 36, Issue 11, 2013, Pages 3591-3598

  Zhao, Wenhui ^a   Katzmarzyk, Peter T ^a   Horswell, Ronald ^a   Wang, Yujie ^a,b   Johnson, Jolene ^c   Heymsfield, Steven B ^a   Cefalu, William T ^a   Ryan, Donna H ^a   Hu, Gang ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b LOUISIANA STATE UNIVERSITY AGRICULTURAL CENTER   (United States)

^c LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN CHOLESTEROL; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; ARTICLE; BLOOD GLUCOSE MONITORING; BODY MASS; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; DIABETES MELLITUS; FEMALE; HEMOGLOBIN BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; LEG AMPUTATION; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SMOKING; SYSTOLIC BLOOD PRESSURE; AMPUTATION; ANALYSIS; BLOOD; COMPLICATION; GLUCOSE BLOOD LEVEL; INCIDENCE; LEG; NON INSULIN DEPENDENT DIABETES MELLITUS; POVERTY; PROPORTIONAL HAZARDS MODEL; RISK; SURGERY;

ADULT; AFRICAN AMERICANS; AMPUTATION; BLOOD GLUCOSE; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INCIDENCE; LOWER EXTREMITY; MALE; MIDDLE AGED; POVERTY; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK; RISK FACTORS;

EID: 84891873374     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc13-0437     Document Type: Article

References (38)

1. Cowie CC, Rust KF, Ford ES, et al. Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006. Diabetes Care 2009;32:287-294
2. Most RS, Sinnock P. The epidemiology of lower extremity amputations in diabetic individuals. Diabetes Care 1983;6:87-91
3. Humphrey LL, Palumbo PJ, Butters MA, et al. The contribution of non-insulindependent diabetes to lower-extremity amputation in the community. Arch Intern Med 1994;154:885-892
4. American Diabetes Association. Economic costs of diabetes in the U.S. in 2012. Diabetes Care 2013;36:1033-1046
5. Gordois A, Scuffham P, Shearer A, Oglesby A, Tobian JA. The health care costs of diabetic peripheral neuropathy in the US. Diabetes Care 2003;26:1790-1795
6. Putting feet first in diabetes. Lancet 2005; 366:1674
7. Jeffcoate W, Edmonds M, Rayman G, Shearman C, Stuart L, Turner B; Putting Feet First Implementation Group. Putting feet first d national guidance at last. Diabet Med 2009;26:1081-1082
8. Li Y, Burrows NR, Gregg EW, Albright A, Geiss LS. Declining rates of hospitalization for nontraumatic lower-extremity amputation in the diabetic population aged 40 years or older: U.S., 1988-2008. Diabetes Care 2012;35:273-277
9. Jeffcoate WJ, Margolis DJ. Incidence of major amputation for diabetes in Scotland sets a target for us all. Diabetes Care 2012; 35:2419-2420
10. Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular andmicrovascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000;321:405-412
11. Davis WA, Norman PE, Bruce DG, Davis TM. Predictors, consequences and costs of diabetes-related lower extremity amputation complicating type 2 diabetes: the Fremantle Diabetes Study. Diabetologia 2006;49:2634-2641
12. Moss SE, Klein R, Klein BE. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. The 14-year incidence of lower-extremity amputations in a diabetic population. Diabetes Care 1999;22:951-959
13. Resnick HE, Carter EA, Sosenko JM, et al.; Strong Heart Study. Incidence of lowerextremity amputation in American Indians: the Strong Heart Study. Diabetes Care 2004;27:1885-1891
14. Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Risk factors predicting lower extremity amputations in patients with NIDDM. Diabetes Care 1996;19:607-612
15. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352: 837-853
16. Patel A, MacMahon S, Chalmers J, et al.; ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358:2560-2572
17. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998;352:854-865
18. Dormandy JA, Charbonnel B, Eckland DJ, et al.; PROactive investigators. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial. Lancet 2005;366: 1279-1289
19. Li W, Wang Y, Chen L, et al. Increasing prevalence of diabetes in middle or low income residents in Louisiana from 2000 to 2009. Diabetes Res Clin Pract 2011;94: 262-268
20. Wang Y, Chen L, Horswell R, et al. Racial differences in the association between gestational diabetes mellitus and risk of type 2 diabetes. J Womens Health (Larchmt) 2012;21:628-633
21. Wang Y, Chen L, Xiao K, et al. Increasing incidence of gestational diabetes mellitus in Louisiana, 1997-2009. J Womens Health (Larchmt) 2012;21:319-325
22. Zhang Y, Li W, Wang Y, et al. Increasing prevalence of hypertension in low income residents within Louisiana State University Health Care Services Division Hospital System. Eur J Intern Med 2012;23: e179-e184
23. Hu G, Horswell R, Wang Y, et al. Body mass index and the risk of dementia among Louisiana low income diabetic patients. PLoS ONE 2012;7:e44537
24. Wang Y, Katzmarzyk PT, Horswell R, et al. Racial disparities in diabetic complications in an underinsured population. J Clin Endocrinol Metab 2012;97:4446-4453
25. American Diabetes Association. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:1183-1197
26. Tseng CL, Sambamoorthi U, Helmer D, et al. The association between mental health functioning and nontraumatic lower extremity amputations in veterans with diabetes. Gen Hosp Psychiatry 2007;29: 537-546
27. Sohn MW, Budiman-Mak E, Stuck RM, Siddiqui F, Lee TA. Diagnostic accuracy of existing methods for identifying diabetic foot ulcers from inpatient and outpatient datasets. J Foot Ankle Res 2010;3:27
28. Cederholm J, Gudbjörnsdottir S, Eliasson B, Zethelius B, Eeg-Olofsson K, Nilsson PM; NDR. Systolic blood pressure and risk of cardiovascular diseases in type 2 diabetes: an observational study from the Swedish national diabetes register. J Hypertens 2010;28:2026-2035
29. Clarke P, Gray A, Holman R. Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62). Med Decis Making 2002;22:340-349
30. Adler AI, Erqou S, Lima TA, Robinson AH. Association between glycated haemoglobin and the risk of lower extremity amputation in patients with diabetes mellitus-review and meta-analysis. Diabetologia 2010;53: 840-849
31. Harati Y. Diabetic peripheral neuropathies. Methodist Debakey Cardiovasc J 2010;6:15-19
32. Lavery LA, Armstrong DG, Vela SA, Quebedeaux TL, Fleischli JG. Practical criteria for screening patients at high risk for diabetic foot ulceration. Arch Intern Med 1998;158:157-162
33. Selvin E, Wattanakit K, Steffes MW, Coresh J, Sharrett AR. HbA1c and peripheral arterial disease in diabetes: the Atherosclerosis Risk in Communities study. Diabetes Care 2006;29:877-882
34. Prompers L, Huijberts M, Apelqvist J, et al. High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study. Diabetologia 2007;50:18-25
35. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med 2000;342:381-389
36. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Effect of intensive diabetes management onmacrovascular events and risk factors in the Diabetes Control and Complications Trial. Am J Cardiol 1995; 75:894-903
37. Karter AJ, Ferrara A, Liu JY, Moffet HH, Ackerson LM, Selby JV. Ethnic disparities in diabetic complications in an insured population. JAMA 2002;287:2519-2527
38. Morris AD, McAlpine R, Steinke D, et al. Diabetes and lower-limb amputations in the community. A retrospective cohort study. DARTS/MEMO Collaboration. Diabetes Audit and Research in Tayside Scotland/Medicines Monitoring Unit. Diabetes Care 1998;21:738-743